Trial intelligence / Profile preview

Nicorandil and Fatigue in Insulin Resistance

NCT03775902Completed

Sponsor
University of Copenhagen
Start
Dec 2018
Primary completion
Jan 2020
Modality
Small Molecules
Countries
1
01

Overview

Randomised, double-blind trial of nicorandil in insulin resistance (IR), sponsored by University of Copenhagen. Primary endpoint: Extracellular potassium concentration measured with microdialysis at 6 weeks. Started Dec 2018; status: completed.

02

Drugs

nicorandil
03

Conditions

insulin resistance (IR)

Beyond the preview

Go deeper on NCT03775902.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT03775902.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call